{{Rsnum
|rsid=1467967
|Gene=MAPT
|Chromosome=17
|position=45908813
|Orientation=plus
|GMAF=0.3829
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MAPT
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 49.5 | 42.3 | 8.1
| HCB | 10.7 | 56.5 | 32.8
| JPT | 18.0 | 55.0 | 27.0
| YRI | 48.6 | 48.6 | 2.7
| ASW | 35.7 | 58.9 | 5.4
| CHB | 10.7 | 56.5 | 32.8
| CHD | 10.6 | 55.8 | 33.7
| GIH | 39.6 | 50.5 | 9.9
| LWK | 48.1 | 42.6 | 9.3
| MEX | 44.8 | 43.1 | 12.1
| MKK | 64.5 | 29.0 | 6.5
| TSI | 52.0 | 40.2 | 7.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20951764
|Title=High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal ?-amyloid in Parkinson disease
}}

{{PMID Auto
|PMID=17266761
|Title=Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease.
|OA=1
}}

{{PMID Auto
|PMID=18065436
|Title=The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.
|OA=1
}}

{{PMID Auto
|PMID=18541914
|Title=Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}